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Opportunistic yeast infections have emerged as an increasing problem in
immunocompromised and debilitated patients. Although Candida albicans is the
yeast most commonly isolated from the body and that which most commonly
causes candidiasis, several reports have documented the emergence of
Torulopsis glabrata as an important pathogen. We describe cases of fungaemia
caused by this yeast in compromised patients which illustrate noteworthy
predispositions.
CASE 1
A female child with a birth weight of 919 g was born by premature normal delivery
at 25 weeks gestation and was transferred to a neonatal intensive care unit.
Respiratory distress syndrome developed and mechanical ventilation was
commenced. Total parenteral nutrition was administered via peripheral venous
cannulae. An eight day prophylactic course of penicillin and gentamicin had been
commenced at birth. Following the isolation of coagulase negative staphylococci
from peripheral venous blood culture and accompanying signs of clinical sepsis, a
further 22 days of flucloxacillin and netilmicin was given. The clinical response
was poor despite in vitro sensitivity of the micro-organism. Her respiratory
secretions were colonised with Pseudomonas spp. and when clinical pulmonary
infection developed, the drug regimen was changed to ceftazidime. Her clinical
deterioration continued and one day later splenomegaly was noted and the
platelet count fell further to 80 x 109/1.
Four sets of blood cultures and urine grew Torulopsis glabrata and she was
commenced on amphotericin 1 mg/kg/day and flucytosine 80 mg/kg/day.
During the next week there was no clinical response and amphotericin and
flucytosine doses were progressively increased to 2 mg/kg/day and 160
mg/kg/day respectively. Her clinical condition improved and the platelet count
rose steadily to 160 x 109/1. A total of 21 days antifungal therapy was
administered, during which liver and renal function remained within normal limits
and she subsequently made satisfactory progress.
CASE 2
A 74-year-old drowsy and dehydrated woman was admitted to a geriatric
medical unit with increasing confusion, and urinary incontinence. She had poorly
controlled non insulin dependent diabetes mellitus, ischaemic heart disease,
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cerebrovascular disease and mild dementia. The plasma glucose level was
56 mmol/l, white cell count 21 x 109/1, and serum urea 26-5 mmol/l.
Intensive therapy with insulin, fluids and diuretics was commenced, and oral
ampicillin 500 mg four times daily. A urinary catheter was passed to monitor
output. She was slow to respond and hyperglycaemia persisted in spite of this
treatment. After ten days she developed abdominal distension and signs of
subacute obstruction. The antibiotic regimen was changed to cephradine and
metronidazole. Direct microscopy of a catheter specimen of urine showed a white
cell count > 1000 cells/cu mm, and yeasts were seen in large numbers.
The peripheral blood white cell count rose from 17 to 23 x 109/1. All antibiotics
were stopped and intravenous amphotericin -commenced at a dose of 0-3
mg/kg/day which was increased to 0*5 mg/kg/day after two days. Torulopsis
glabrata was isolated from urine and three sets of blood cultures. There was
a slow clinical improvement, accompanied by a slight fall in blood urea and
creatinine levels and a normalisation of blood glucose. Amphotericin was
continued for 11 days, by which time she was considered clinically to be no
longer septicaemic. Catheter specimens of urine were clearer but some yeasts
were still seen on microscopy. Unfortunately intractable congestive cardiac failure
and right basal pulmonary consolidation led to death 34 days after admission.
CASE 3
A 60-year-old woman was admitted to hospital with a large perforated gastric
ulcer. A partial gastrectomy was performed and she was commenced on
mezlocillin and metronidazole. Postoperatively the patient was pyrexial, and
amoxycillin was substituted for meziocillin, with netilmicin added. A subclavian
central venous catheter and an arterial catheter were inserted and the patient
required assisted ventilation in a respiratory intensive care unit. Ten days
postoperatively the gastroduodenostomy anastomosis failed and the abdominal
wound burst, requiring emergency repair. A tracheostomy was also performed.
Overthe succeeding eight weeks theclinical course was stormy with a persistently
spiking pyrexia, bile drainage, respiratory difficulty, depressed level of conscious-
ness and a progressive flaccid peripheral motor neuropathy.
During this period clavulanate potentiated ampicillin, azlocillin and ceftazidime
were successively prescribed while netilmicin and metronidazole were admin-
istered almost continuously. Candida albicans was first isolated from a catheter
specimen of urine four days after admission and was subsequently isolated
intermittently from sputum and wound swabs. Morphologically different yeasts,
initially reported as "non pathogenic", were first isolated from a wound swab
on day 15 and from sputum ten days later. Sixty days after admission her
temperature rose to 40°C and two-sets of blood cultures grew yeasts which were
identified as Torulopsis glabrata. Culture of the subclavian catheter tip, removed
two days later also yielded this organism. Amphotericin therapy 1 5 mg/kg on
alternate days was given. The patient became apyrexic after 24 hours and
remained so. Treatment was continued for eight days at which time netilmicin
and metronidazole were also stopped. The urinary catheter was removed 12 days
later, and she was discharged 21 weeks after admission.
CASE 4
A 42-year-old man presented with small bowel infarction which was treated
by resection followed by jejunostomy. Thereafter he was maintained on total
parenteral nutrition. He suffered repeated episodes of coagulase negative
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staphylococcal infection related to central venous catheters over a period of four
months. These were treated by various antibiotics and replacement of the lines.
A mild fungaemia in which Candida albicans was isolated from blood and
catheter culture responded to removal of the catheter without antifungal therapy.
A tunnelled venous catheter was inserted to allow continued parenteral feeding.
Three days later he became profoundly septicaemic and hypotensive. Torulopsis
glabrata was isolated from four sets of blood cultures and also from the catheter
following its removal. Low dose amphotericin (0 5 mg/kg/day) and full dose
flucytosine were commenced. Afterone week amphotericin dosage was increased
gradually to 1* 5 mg/kg/day and the patient responded temporarily but continued
to show intermittent pyrexia of 385°C. Antifungal therapy continued for three
weeks after which time he appeared stable and afebrile, but he died from
bronchopneumonia two weeks later.
DISCUSSION
Torulopsis berlese, the name first coined by Berlese in 1884 included a number
of yeast species. Torulopsis glabrata was first recognised by Anderson in 1917 1
and was thought to be a species of Cryptococcus because it produced no
ascospores or hyphae. T. glabrata grows on routine bacteriological diagnostic
culture media. Unlike Candida spp. the genus Torulopsis is distinguished by the
complete absence of hyphal or pseudohyphal forms under all cultural conditions
because it reproduces by budding only. The assimilation of trehalose and glucose
but not other sugars confirms the identity,2 but because of its close antigenic
relationship to Candida it is often identified as "Candida species/non albicans"
on the basis of germ tube tests. The organism is sensitive to amphotericin
and normally also to flucytosine, but it is generally resistant to ketoconazole.
Susceptibility to miconazole is variable, up to 40% of strains being resistant.3
T. glabrata was formerly considered to be wholly saprophytic but has become
increasingly recognised as an opportunistic pathogen in the altered host. Like
Candida spp. it may be found as a commensal in the gastrointestinal, respiratory
and genitourinary tracts of normal individuals. Particularly at risk are those who
have undergone major gastrointestinal surgery requiring prolonged intravenous
feeding, have had broad spectrum antibiotics, diabetics, or immunocompromised
patients.
The spectrum of infection ranges from mild fungaemia to endocarditis,4 pyelone-
phritis,5 pneumonitis,6 and peritonitis.7 The compromised host is particularly
liable to tissue invasion and metastatic infected foci. Experimental pathogenicity
studies on T. glabrata have demonstrated that the yeast does not produce a
progressive infection in normal mice, but the capacity for tissue invasion was
enhanced in steroid
-treated, alloxan -diabetic and irradiated mice.8 Normal
human plasma inhibits the growth of T. glabrata more than other yeasts in vitro,
the inhibitory factor being a combination oftransferrin, IgM and other unidentified
proteins.9 The clinical presentation is undistinguishable from systemic candidosis,
and can vary from an indolent low grade pyrexia to profound septicaemia with
shock.
The first case illustrates the pathogenic potential of the yeast in a very pre-term
neonate. Multiple invasive procedures, the prescription of broad spectrum
antibiotics over a long period along with intravenous feeding enabled the
organism to invade systemically. A very high dose antifungal regimen was
required to produce a clinical cure. This was tolerated well by the infant, with no
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evidence of renal or haematological toxicity. Case two became fungaemic
following urinary catheter colonisation. Impaired renal function does not demand
a reduction in amphotericin dosage since only 3% is excreted in the urine.10
However, low dosage regimens are being increasingly used to reduce toxicity,
particularly when the drug is used in combination with flucytosine. Since
flucytosine is mainly excreted through the kidneys, the addition of this drug is
particularly appropriate in treating fungaemia associated with renal tract infection.
The regimen has been combined with local instillations of amphotericin into the
bladder,5 but bladder colonisation cannot beeradicated without catheter removal.
Poor diabetic control adds to the difficulties of treatment since hyperglycaemia
and acidosis interfere with polymorphonuclear phagocytosis."
The third and fourth cases represent typical examples of initial colonization of a
central venous catheter and subsequent fungaemia due to the yeast after
gastrointestinal surgery, prolonged antibiotic therapy and intravenous feeding.
Removal of intravenous catheters and subsequent alternate day treatment with
amphotericin alone for 10 days was successful in rapidly eradicating the infection
in case three. Case four showed spontaneous recovery following removal of the
central catheter, but general deterioration compromised his ability to respond to
the subsequent T. glabrata septicaemia. Metastatic seeding may have occurred
prior to diagnosis or to catheter removal, or to the establishment of therapeutic
antifungal serum concentrations. Such events are often only diagnosed at post-
mortem. Systemic infection with T. glabrata is a life,-threatening event in the
metabolically or immunologically compromised patient. It is particularly likely to
occur following broad spectrum antibacterial therapy or to the prophylactic or
therapeutic administration of imidazoles.
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